| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.857 | 0.004 | 0.857 | Antiadrenergic | 0.854 0.004 CID_154699479 | ||
| 0.856 | 0.004 | 0.856 | Adrenaline antagonist | 0.853 0.004 CID_154699479 | ||
| 0.775 | 0.004 | 0.803 | Spasmolytic | 0.803 0.004 CID_154699479 | CID_154699479 | |
| 0.755 | 0.004 | 0.755 | Vasodilator, coronary | 0.716 0.004 CID_154699479 | ||
| 0.753 | 0.005 | 0.753 | Cardiotonic | 0.736 0.005 CID_154699479 | ||
| 0.749 | 0.001 | 0.749 | Beta adrenoreceptor antagonist | 0.649 0.002 CID_154699479 | ||
| 0.682 | 0.008 | 0.705 | Vasodilator, peripheral | 0.705 0.006 CID_154699479 | CID_154699479 | |
| 0.681 | 0.016 | 0.681 | Cyclophilin D inhibitor | 0.532 0.042 CID_154699479 | ||
| 0.635 | 0.001 | 0.635 | Beta 1 adrenoreceptor antagonist | 0.542 0.002 CID_154699479 | ||
| 0.631 | 0.004 | 0.669 | Anesthetic local | 0.669 0.003 CID_154699479 | CID_154699479 | |
| 0.588 | 0.009 | 0.588 | Hypoglycemic | 0.428 0.023 CID_154699479 | ||
| 0.575 | 0.024 | 0.575 | Antiobesity | 0.462 0.046 CID_154699479 | ||
| 0.545 | 0.021 | 0.545 | 5 Hydroxytryptamine release stimulant | 0.509 0.026 CID_154699479 | ||
| 0.52 | 0.01 | 0.532 | Vasodilator | 0.532 0.01 CID_154699479 | CID_154699479 | |
| 0.491 | 0.002 | 0.491 | Beta 2 adrenoreceptor antagonist | 0.452 0.002 CID_154699479 | ||
| 0.495 | 0.03 | 0.495 | Antithrombotic | 0.435 0.041 CID_154699479 | ||
| 0.487 | 0.035 | 0.54 | Cholesterol antagonist | 0.54 0.026 CID_154699479 | CID_154699479 | |
| 0.449 | 0.004 | 0.449 | Nav1.3 sodium channel blocker | 0.446 0.004 CID_154699479 | ||
| 0.446 | 0.005 | 0.446 | Insulin sensitizer | 0.323 0.012 CID_154699479 | ||
| 0.44 | 0.003 | 0.469 | Adrenaline agonist | 0.469 0.002 CID_154699479 | CID_154699479 | |
| 0.412 | 0.014 | 0.424 | Sodium/bile acid cotransporter inhibitor | 0.424 0.011 CID_154699479 | CID_154699479 | |
| 0.412 | 0.015 | 0.443 | P-glycoprotein inhibitor | 0.443 0.012 CID_154699479 | CID_154699479 | |
| 0.347 | 0.009 | 0.347 | Insulin secretagoues | 0.336 0.009 CID_154699479 | ||
| 0.336 | 0.002 | 0.363 | Beta adrenoreceptor agonist | 0.363 0.002 CID_154699479 | CID_154699479 | |
| 0.365 | 0.032 | 0.365 | Hypolipemic | 0.258 0.064 CID_154699479 | ||
| 0.406 | 0.074 | 0.441 | 5 Hydroxytryptamine release inhibitor | 0.441 0.055 CID_154699479 | CID_154699479 | |
| 0.386 | 0.054 | 0.386 | Immunostimulant | 0.363 0.061 CID_154699479 | ||
| 0.337 | 0.007 | 0.337 | Calcium channel blocker | 0.268 0.014 CID_154699479 | ||
| 0.342 | 0.018 | 0.342 | DNA methylase inhibitor | 0.276 0.036 CID_154699479 | ||
| 0.323 | 0.019 | 0.323 | DNA methyltransferase I inhibitor | 0.281 0.034 CID_154699479 | ||
| 0.381 | 0.085 | 0.469 | Histamine release inhibitor | 0.469 0.041 CID_154699479 | CID_154699479 | |
| 0.284 | 0.002 | 0.284 | Beta 1 adrenoreceptor agonist | 0.21 0.002 CID_154699479 | ||
| 0.287 | 0.005 | 0.287 | Calcium antagonist | 0.242 0.009 CID_154699479 | ||
| 0.265 | 0.003 | 0.299 | Beta 3 adrenoreceptor antagonist | 0.299 0.003 CID_154699479 | CID_154699479 | |
| 0.293 | 0.034 | 0.303 | Growth hormone agonist | 0.303 0.032 CID_154699479 | CID_154699479 | |
| 0.371 | 0.13 | 0.438 | Caspase 9 stimulant | 0.438 0.089 CID_154699479 | CID_154699479 | |
| 0.259 | 0.021 | 0.363 | Alpha-N-acetylglucosaminidase inhibitor | 0.363 0.011 CID_154699479 | CID_154699479 | |
| 0.291 | 0.069 | 0.524 | Aldehyde oxidase inhibitor | 0.524 0.03 CID_154699479 | CID_154699479 | |
| 0.233 | 0.012 | 0.233 | Toll-Like receptor 2 antagonist | 0.202 0.023 CID_154699479 | ||
| 0.215 | 0.016 | 0.215 | Nav1.1 sodium channel blocker | 0.215 0.016 CID_154699479 | ||
| 0.199 | 0.005 | 0.199 | Calcium channel L-type blocker | 0.17 0.008 CID_154699479 | ||
| 0.234 | 0.045 | 0.234 | Nitric-oxide synthase stimulant | 0.223 0.056 CID_154699479 | ||
| 0.262 | 0.075 | 0.262 | Transcription factor STAT3 inhibitor | 0.227 0.104 CID_154699479 | ||
| 0.249 | 0.067 | 0.267 | DNA synthesis inhibitor | 0.267 0.057 CID_154699479 | CID_154699479 | |
| 0.201 | 0.019 | 0.201 | Nav1.6 sodium channel blocker | 0.181 0.028 CID_154699479 | ||
| 0.175 | 0.002 | 0.201 | Beta 2 adrenoreceptor agonist | 0.201 0.002 CID_154699479 | CID_154699479 | |
| 0.17 | 0.002 | 0.17 | Beta 3 adrenoreceptor agonist | 0.164 0.002 CID_154699479 | ||
| 0.186 | 0.022 | 0.209 | Adenylate cyclase stimulant | 0.209 0.01 CID_154699479 | CID_154699479 | |
| 0.272 | 0.112 | 0.342 | Transcription factor NF kappa B inhibitor | 0.342 0.079 CID_154699479 | CID_154699479 | |
| 0.18 | 0.022 | 0.18 | Calcium channel (voltage-sensitive) blocker | 0.141 0.039 CID_154699479 | ||
| 0.279 | 0.129 | 0.323 | Immunosuppressant | 0.323 0.101 CID_154699479 | CID_154699479 | |
| 0.156 | 0.009 | 0.156 | Glutamate release inhibitor | 0.146 0.011 CID_154699479 | ||
| 0.277 | 0.13 | 0.326 | Calpain 2 inhibitor | 0.326 0.099 CID_154699479 | CID_154699479 | |
| 0.188 | 0.049 | 0.188 | Diuretic | 0.17 0.061 CID_154699479 | ||
| 0.159 | 0.021 | 0.197 | Sphingomyelinase inhibitor | 0.197 0.01 CID_154699479 | CID_154699479 | |
| 0.163 | 0.025 | 0.194 | Mucolytic | 0.194 0.015 CID_154699479 | CID_154699479 | |
| 0.251 | 0.114 | 0.251 | Immunomodulator | 0.24 0.123 CID_154699479 | ||
| 0.211 | 0.078 | 0.211 | Interleukin antagonist | 0.172 0.102 CID_154699479 | ||
| 0.168 | 0.037 | 0.168 | MAP3K9 inhibitor | 0.146 0.067 CID_154699479 | ||
| 0.16 | 0.031 | 0.182 | Expectorant | 0.182 0.025 CID_154699479 | CID_154699479 | |
| 0.154 | 0.027 | 0.162 | Mediator release inhibitor | 0.162 0.024 CID_154699479 | CID_154699479 | |
| 0.155 | 0.03 | 0.179 | Bronchodilator | 0.179 0.022 CID_154699479 | CID_154699479 | |
| 0.127 | 0.005 | 0.163 | Sphingosine 1-phosphate receptor 3 agonist | 0.163 0.004 CID_154699479 | CID_154699479 | |
| 0.126 | 0.004 | 0.203 | Sphingosine 1-phosphate receptor agonist | 0.203 0.003 CID_154699479 | CID_154699479 | |
| 0.159 | 0.039 | 0.176 | Adenylate cyclase inhibitor | 0.176 0.031 CID_154699479 | CID_154699479 | |
| 0.165 | 0.049 | 0.184 | Nav1.2 sodium channel blocker | 0.184 0.041 CID_154699479 | CID_154699479 | |
| 0.142 | 0.026 | 0.142 | Toll-Like receptor 4 antagonist | 0.128 0.036 CID_154699479 | ||
| 0.132 | 0.017 | 0.132 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.121 | 0.012 | 0.121 | Cathepsin D inhibitor | 0.112 0.015 CID_154699479 | ||
| 0.14 | 0.032 | 0.15 | Gastric antisecretory | 0.15 0.027 CID_154699479 | CID_154699479 | |
| 0.137 | 0.029 | 0.166 | Catalase inhibitor | 0.166 0.022 CID_154699479 | CID_154699479 | |
| 0.142 | 0.034 | 0.142 | Caspase 3 inhibitor | 0.119 0.062 CID_154699479 | ||
| 0.136 | 0.037 | 0.136 | Protease inhibitor | 0.135 0.038 CID_154699479 | ||
| 0.102 | 0.004 | 0.178 | Sphingosine 1-phosphate receptor 1 agonist | 0.178 0.003 CID_154699479 | CID_154699479 | |
| 0.12 | 0.023 | 0.12 | Somatostatin 1 agonist | 0.114 0.026 CID_154699479 | ||
| 0.194 | 0.098 | 0.291 | Cyclic AMP phosphodiesterase inhibitor | 0.291 0.046 CID_154699479 | CID_154699479 | |
| 0.099 | 0.004 | 0.105 | Calcium-sensing receptor antagonist | 0.105 0.004 CID_154699479 | CID_154699479 | |
| 0.184 | 0.09 | 0.235 | Psychostimulant | 0.235 0.064 CID_154699479 | CID_154699479 | |
| 0.246 | 0.152 | 0.246 | Calcium channel activator | |||
| 0.143 | 0.051 | 0.143 | Proteasome inhibitor | 0.14 0.052 CID_154699479 | ||
| 0.152 | 0.062 | 0.152 | Neuropeptide Y1 antagonist | 0.137 0.087 CID_154699479 | ||
| 0.093 | 0.003 | 0.093 | Plasmepsin I inhibitor | 0.069 0.004 CID_154699479 | ||
| 0.215 | 0.126 | 0.26 | Gastrin inhibitor | 0.26 0.068 CID_154699479 | CID_154699479 | |
| 0.157 | 0.068 | 0.18 | Phospholipase A2 inhibitor | 0.18 0.054 CID_154699479 | CID_154699479 | |
| 0.157 | 0.068 | 0.157 | Acetylcholine M1 receptor antagonist | 0.14 0.085 CID_154699479 | ||
| 0.109 | 0.025 | 0.109 | Selectin antagonist | 0.104 0.026 CID_154699479 | ||
| 0.094 | 0.009 | 0.109 | Sphingosine kinase inhibitor | 0.109 0.006 CID_154699479 | CID_154699479 | |
| 0.193 | 0.109 | 0.223 | Peptidyltransferase inhibitor | 0.223 0.073 CID_154699479 | CID_154699479 | |
| 0.121 | 0.038 | 0.124 | Factor V inhibitor | 0.124 0.035 CID_154699479 | CID_154699479 | |
| 0.091 | 0.009 | 0.116 | Epithelial sodium channel blocker | 0.116 0.005 CID_154699479 | CID_154699479 | |
| 0.089 | 0.009 | 0.102 | Alpha-mannosidase inhibitor | 0.102 0.006 CID_154699479 | CID_154699479 | |
| 0.084 | 0.005 | 0.087 | Plasmepsin II inhibitor | 0.087 0.005 CID_154699479 | CID_154699479 | |
| 0.117 | 0.038 | 0.183 | MAP kinase kinase 1 inhibitor | 0.183 0.007 CID_154699479 | CID_154699479 | |
| 0.084 | 0.008 | 0.102 | Mannosidase inhibitor | 0.102 0.005 CID_154699479 | CID_154699479 | |
| 0.154 | 0.079 | 0.159 | Thrombolytic | 0.159 0.075 CID_154699479 | CID_154699479 | |
| 0.136 | 0.061 | 0.154 | Cyclooxygenase 3 inhibitor | 0.154 0.045 CID_154699479 | CID_154699479 | |
| 0.19 | 0.123 | 0.218 | Calpain inhibitor | 0.218 0.096 CID_154699479 | CID_154699479 | |
| 0.192 | 0.128 | 0.192 | Interleukin agonist | |||
| 0.205 | 0.141 | 0.223 | 5 Hydroxytryptamine uptake stimulant | 0.223 0.113 CID_154699479 | CID_154699479 | |
| 0.128 | 0.066 | 0.128 | Cathepsin H inhibitor | 0.123 0.072 CID_154699479 | ||
| 0.078 | 0.016 | 0.099 | Sphingosine kinase 2 inhibitor | 0.099 0.008 CID_154699479 | CID_154699479 | |
| 0.078 | 0.017 | 0.078 | Glucosylceramidase inhibitor | 0.069 0.023 CID_154699479 | ||
| 0.088 | 0.027 | 0.088 | Secretase beta inhibitor | 0.086 0.03 CID_154699479 | ||
| 0.159 | 0.1 | 0.159 | Hepatoprotectant | |||
| 0.08 | 0.022 | 0.08 | Nitric oxide donor | 0.077 0.025 CID_154699479 | ||
| 0.064 | 0.008 | 0.076 | Sphingosine kinase 1 inhibitor | 0.076 0.005 CID_154699479 | CID_154699479 | |
| 0.191 | 0.136 | 0.21 | Neuropeptide Y2 antagonist | 0.21 0.103 CID_154699479 | CID_154699479 | |
| 0.114 | 0.06 | 0.114 | Chelator | 0.114 0.06 CID_154699479 | ||
| 0.153 | 0.1 | 0.188 | Phospholipase C inhibitor | 0.188 0.053 CID_154699479 | CID_154699479 | |
| 0.174 | 0.122 | 0.183 | Platelet antagonist | 0.183 0.115 CID_154699479 | CID_154699479 | |
| 0.069 | 0.018 | 0.079 | 5 Hydroxytryptamine 1B agonist | 0.079 0.013 CID_154699479 | CID_154699479 | |
| 0.066 | 0.017 | 0.066 | Lysophosphatidic acid 3 receptor antagonist | 0.061 0.022 CID_154699479 | ||
| 0.113 | 0.064 | 0.113 | Nav1.5 sodium channel blocker | 0.11 0.068 CID_154699479 | ||
| 0.096 | 0.052 | 0.128 | Triose-phosphate isomerase inhibitor | 0.128 0.028 CID_154699479 | CID_154699479 | |
| 0.114 | 0.071 | 0.114 | Calcium channel N-type blocker | 0.106 0.085 CID_154699479 | ||
| 0.079 | 0.036 | 0.104 | Phosphodiesterase III inhibitor | 0.104 0.021 CID_154699479 | CID_154699479 | |
| 0.069 | 0.029 | 0.069 | Calcium channel P-type blocker | 0.062 0.049 CID_154699479 | ||
| 0.191 | 0.151 | 0.191 | Transcription factor STAT inhibitor | |||
| 0.072 | 0.032 | 0.072 | Neuraminidase (influenza) inhibitor | 0.07 0.035 CID_154699479 | ||
| 0.053 | 0.014 | 0.053 | Squalene synthetase inhibitor | 0.038 0.019 CID_154699479 | ||
| 0.055 | 0.016 | 0.058 | HIV-1 protease inhibitor | 0.058 0.014 CID_154699479 | CID_154699479 | |
| 0.141 | 0.103 | 0.195 | Interleukin 6 antagonist | 0.195 0.043 CID_154699479 | CID_154699479 | |
| 0.081 | 0.047 | 0.161 | Keratolytic | 0.161 0.013 CID_154699479 | CID_154699479 | |
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | 0.029 0.025 CID_154699479 | ||
| 0.066 | 0.037 | 0.066 | Neuraminidase inhibitor | 0.062 0.041 CID_154699479 | ||
| 0.062 | 0.033 | 0.062 | Human rhinovirus A protease inhibitor | |||
| 0.086 | 0.057 | 0.086 | Transcription factor NF kappa B stimulant | 0.085 0.06 CID_154699479 | ||
| 0.087 | 0.059 | 0.102 | Ornithine decarboxylase inhibitor | 0.102 0.043 CID_154699479 | CID_154699479 | |
| 0.108 | 0.081 | 0.108 | Acetylcholine muscarinic antagonist | 0.102 0.088 CID_154699479 | ||
| 0.171 | 0.144 | 0.24 | DNA damaging | 0.24 0.086 CID_154699479 | CID_154699479 | |
| 0.046 | 0.02 | 0.046 | Renin inhibitor | 0.04 0.023 CID_154699479 | ||
| 0.086 | 0.06 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.092 0.047 CID_154699479 | CID_154699479 | |
| 0.067 | 0.041 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.111 | 0.087 | 0.221 | Amylase inhibitor | 0.221 0.037 CID_154699479 | CID_154699479 | |
| 0.086 | 0.063 | 0.106 | NADH dehydrogenase inhibitor | 0.106 0.038 CID_154699479 | CID_154699479 | |
| 0.072 | 0.049 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.06 | 0.038 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | 0.068 0.028 CID_154699479 | CID_154699479 | |
| 0.118 | 0.096 | 0.118 | Lipid peroxidase inhibitor | 0.111 0.104 CID_154699479 | ||
| 0.073 | 0.051 | 0.073 | Metalloproteinase-9 inhibitor | 0.071 0.054 CID_154699479 | ||
| 0.05 | 0.028 | 0.056 | Cytokine production stimulant | 0.056 0.018 CID_154699479 | CID_154699479 | |
| 0.199 | 0.18 | 0.238 | Apoptosis antagonist | 0.238 0.14 CID_154699479 | CID_154699479 | |
| 0.06 | 0.041 | 0.06 | Cathepsin E inhibitor | 0.058 0.044 CID_154699479 | ||
| 0.081 | 0.063 | 0.094 | Histamine H2 receptor antagonist | 0.094 0.041 CID_154699479 | CID_154699479 | |
| 0.071 | 0.052 | 0.092 | Aminopeptidase I inhibitor | 0.092 0.032 CID_154699479 | CID_154699479 | |
| 0.09 | 0.073 | 0.124 | Aminopeptidase B inhibitor | 0.124 0.05 CID_154699479 | CID_154699479 | |
| 0.111 | 0.095 | 0.115 | Bone formation stimulant | 0.115 0.09 CID_154699479 | CID_154699479 | |
| 0.049 | 0.033 | 0.049 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.062 | 0.047 | 0.062 | Glucagon-like peptide 1 agonist | 0.06 0.048 CID_154699479 | ||
| 0.05 | 0.035 | 0.064 | Squalene epoxidase inhibitor | 0.064 0.017 CID_154699479 | CID_154699479 | |
| 0.033 | 0.019 | 0.033 | Prostaglandin agonist | 0.03 0.022 CID_154699479 | ||
| 0.146 | 0.134 | 0.146 | Anticonvulsant | |||
| 0.026 | 0.015 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 CID_154699479 | ||
| 0.035 | 0.025 | 0.051 | Ceramide glucosyltransferase inhibitor | 0.051 0.006 CID_154699479 | CID_154699479 | |
| 0.044 | 0.034 | 0.044 | Phosphorylase inhibitor | |||
| 0.087 | 0.077 | 0.087 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.044 | 0.034 | 0.044 | Parathyroid hormone antagonist | |||
| 0.084 | 0.075 | 0.088 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.088 0.068 CID_154699479 | CID_154699479 | |
| 0.073 | 0.064 | 0.083 | Interferon agonist | 0.083 0.048 CID_154699479 | CID_154699479 | |
| 0.044 | 0.036 | 0.044 | Antimetabolite | |||
| 0.059 | 0.052 | 0.059 | Neutrophil collagenase inhibitor | 0.057 0.055 CID_154699479 | ||
| 0.049 | 0.042 | 0.049 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.048 | 0.043 | 0.048 | Ribonucleotide reductase inhibitor | |||
| 0.085 | 0.08 | 0.114 | UDP-glucose 4-epimerase inhibitor | 0.114 0.048 CID_154699479 | CID_154699479 | |
| 0.024 | 0.021 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 CID_154699479 | CID_154699479 | |
| 0.03 | 0.026 | 0.036 | Growth hormone releasing factor agonist | 0.036 0.021 CID_154699479 | CID_154699479 | |
| 0.016 | 0.013 | 0.02 | Vitamin D receptor agonist | 0.02 0.007 CID_154699479 | CID_154699479 | |
| 0.112 | 0.11 | 0.144 | Vanilloid 1 agonist | 0.144 0.045 CID_154699479 | CID_154699479 | |
| 0.028 | 0.026 | 0.028 | Prostaglandin D2 agonist | |||
| 0.03 | 0.028 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.084 | 0.085 | 0.089 | Toll-Like receptor 3 antagonist | 0.089 0.072 CID_154699479 | CID_154699479 | |
| 0.089 | 0.09 | 0.098 | Folate antagonist | 0.098 0.068 CID_154699479 | CID_154699479 | |
| 0.093 | 0.097 | 0.167 | Alkylator | 0.167 0.038 CID_154699479 | CID_154699479 | |
| 0.057 | 0.062 | 0.063 | Interferon inducer | 0.063 0.047 CID_154699479 | CID_154699479 | |
| 0.016 | 0.022 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 CID_154699479 | CID_154699479 | |
| 0.047 | 0.054 | 0.051 | Cathepsin B inhibitor | 0.051 0.046 CID_154699479 | CID_154699479 | |
| 0.056 | 0.064 | 0.091 | Phenylalanine 4-hydroxylase inhibitor | 0.091 0.03 CID_154699479 | CID_154699479 | |
| 0.099 | 0.107 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.1 CID_154699479 | CID_154699479 | |
| 0.02 | 0.029 | 0.04 | Uridine phosphorylase inhibitor | 0.04 0.012 CID_154699479 | CID_154699479 | |
| 0.103 | 0.113 | 0.116 | Antibacterial (Helicobacter pylori) | 0.116 0.087 CID_154699479 | CID_154699479 | |
| 0.096 | 0.106 | 0.157 | Aldehyde dehydrogenase inhibitor | 0.157 0.044 CID_154699479 | CID_154699479 | |
| 0.07 | 0.081 | 0.092 | Glutathione S-transferase inhibitor | 0.092 0.045 CID_154699479 | CID_154699479 | |
| 0.035 | 0.047 | 0.054 | Adenosine deaminase inhibitor | 0.054 0.026 CID_154699479 | CID_154699479 | |
| 0.037 | 0.05 | 0.048 | Neuraminidase (Influenza A) inhibitor | 0.048 0.026 CID_154699479 | CID_154699479 | |
| 0.029 | 0.046 | 0.039 | Vascular adhesion protein 1 inhibitor | 0.039 0.026 CID_154699479 | CID_154699479 | |
| 0.039 | 0.06 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.041 CID_154699479 | CID_154699479 | |
| 0.009 | 0.031 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_154699479 | CID_154699479 | |
| 0.041 | 0.064 | 0.049 | Myc inhibitor | 0.049 0.047 CID_154699479 | CID_154699479 | |
| 0.043 | 0.068 | 0.063 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 CID_154699479 | CID_154699479 | |
| 0.035 | 0.059 | 0.051 | Ornithine carbamoyltransferase inhibitor | 0.051 0.038 CID_154699479 | CID_154699479 | |
| 0.111 | 0.136 | 0.133 | Hemostatic | 0.133 0.091 CID_154699479 | CID_154699479 | |
| 0.071 | 0.104 | 0.083 | Estrogen-related receptor beta agonist | 0.083 0.057 CID_154699479 | CID_154699479 | |
| 0.024 | 0.057 | 0.032 | Purinergic P2X3 antagonist | 0.032 0.028 CID_154699479 | CID_154699479 | |
| 0.015 | 0.049 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.019 CID_154699479 | CID_154699479 | |
| 0.141 | 0.176 | 0.159 | Antioxidant | 0.159 0.154 CID_154699479 | CID_154699479 | |
| 0.019 | 0.056 | 0.025 | Myristoyl transferase inhibitor | 0.025 0.024 CID_154699479 | CID_154699479 | |
| 0.108 | 0.147 | 0.133 | Thiol protease inhibitor | 0.133 0.092 CID_154699479 | CID_154699479 | |
| 0.083 | 0.125 | 0.102 | Microtubule formation inhibitor | 0.102 0.087 CID_154699479 | CID_154699479 | |
| 0.043 | 0.086 | 0.065 | Fibroblast growth factor 2 antagonist | 0.065 0.046 CID_154699479 | CID_154699479 | |
| 0.107 | 0.153 | 0.171 | Angiogenesis stimulant | 0.171 0.11 CID_154699479 | CID_154699479 | |
| 0.05 | 0.096 | 0.075 | Topoisomerase II alpha inhibitor | 0.075 0.057 CID_154699479 | CID_154699479 | |
| 0.065 | 0.113 | 0.103 | Alcohol dehydrogenase inhibitor | 0.103 0.05 CID_154699479 | CID_154699479 | |
| 0.179 | 0.23 | 0.215 | Interleukin 2 agonist | 0.215 0.165 CID_154699479 | CID_154699479 | |
| 0.113 | 0.191 | 0.134 | ATPase inhibitor | 0.134 0.132 CID_154699479 | CID_154699479 | |
| 0.058 | 0.138 | 0.091 | Falcipain 3 inhibitor | 0.091 0.08 CID_154699479 | CID_154699479 | |
| 0.063 | 0.151 | 0.083 | Vanilloid agonist | 0.083 0.062 CID_154699479 | CID_154699479 | |
| 0.16 | 0.248 | 0.191 | Caspase 3 stimulant | 0.191 0.183 CID_154699479 | CID_154699479 | |
| 0.08 | 0.17 | 0.116 | Peroxidase inhibitor | 0.116 0.104 CID_154699479 | CID_154699479 | |
| 0.041 | 0.133 | 0.075 | Phospholipase D inhibitor | 0.075 0.043 CID_154699479 | CID_154699479 | |
| 0.098 | 0.192 | 0.13 | Melanin inhibitor | 0.13 0.114 CID_154699479 | CID_154699479 | |
| 0.062 | 0.172 | 0.155 | MAP kinase kinase inhibitor | 0.155 0.049 CID_154699479 | CID_154699479 | |
| 0.074 | 0.204 | 0.11 | Protein kinase stimulant | 0.11 0.104 CID_154699479 | CID_154699479 | |
| 0.066 | 0.292 | 0.147 | MAP kinase kinase 2 inhibitor | 0.147 0.124 CID_154699479 | CID_154699479 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |